Skip to main content

Roche Value Stock - Dividend - Research Selection

Roche Holding

ISIN: CH0012032048, WKN: 855167

Market price date: 21.05.2021
Market price: 307,45 CHF

Roche Holding Fundamental data and company key figures of the share

Annual reports in CHF
Key figures 28-04-2021
Cash flow
Net operating cash flow
Capital Expenditures -3.530.000.000
Free cash flow 14.629.999.616
Balance sheet
Total Equity 39.773.000.000
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted) 16,520
Diluted shares outstanding 865.000.000
Net sales/revenue 58.323.000.000

Fundamental ratios calculated on: 21-05-2021

Key figures 21-05-2021
Cash flow
P/C 14,65
P/FC 18,18
Balance sheet
Income statement
Div. Yield2,96%

Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.

Market Capitalization272.428.040.192,00 USD
Raw Data SourceIFRS in Millionen CHF
Stock Split2001-05-04,100.0000/1.0000; 2000-05-30,2.0000/1.0000; 1995-07-31,2.0000/1.0000

Description of the company

Roche Holding AG is a research-based healthcare company. The Company develops, manufactures and delivers medicines, and diagnostic instruments and tests. Its operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. Its Pharmaceuticals division consists of two business segments: Roche Pharmaceuticals and Chugai. Its Diagnostics division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. It develops medicines for the disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its product portfolio consists of Pharmaceuticals, Solutions for Diagnostics and Products for Researchers. Its Pharmaceutical products include ACTEMRA and CellCept. Its Solutions for Diagnostics products include Accu-Chek Active System and Accu-Chek Aviva Nano System. The Company's Products for Researchers include Cedex HiRes and Genome Sequencer FLX System.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources::,,